Products from TargetMol
TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.
More information at: www.targetmol.com
No results were found for the filter!
Baloramotide
Item number: TGM-T82925-1mg
Description: Baloramotide, a recombinant protein comprising 182 amino acids from NY-ESO-1, enhances the immune response to tumors [1].
| CAS | 2207581-19-7 |
Please request pricing for this article.
Azintuxizumab
Item number: TGM-T82927-10mg
Description: Azintuxizumab, an IgG4 bispecific antibody, is designed to specifically recognize and bind to the B-cell maturation antigen (BCMA), a molecular marker associated with plasma cell malignancies. Azintuxizumab shows significant promise in preclinical and translational research investigating therapeutic...
From 233.00€
*
AVSEHQLLHDKGKSIQDLRRRFFLHHLI-{Aib}-EIHTAYRFGG
Item number: TGM-T82929-50mg
Description: The compound AVSEHQLLHD KGKSIQDLRR RFFLHHLI-{Aib}-EIHTAYRFGG facilitates bone ossification and has potential applications in the study of conditions associated with osteogenic insufficiency or diminished bone mineral density (BMD), including osteoporosis [1].
| CAS | 2640019-27-6 |
Please request pricing for this article.
Aurora A inhibitor 3
Item number: TGM-T82931-50mg
Description: Aurora A Inhibitor 3 (Compound 5h) effectively inhibits Aurora-A kinase, exhibiting an IC50 of 0.78 µM, and demonstrates cytotoxicity against MCF-7 and MDA-MB-231 cell lines with GI50 values of 0.12 µM and 0.63 µM, respectively [1]. Target: Aurora Kinase
Please request pricing for this article.
AuM1Phe
Item number: TGM-T82934-50mg
Description: AuM1Phe, an N-heterocyclic carbene (NHC) metal complex, inhibits both human topoisomerase I activity and actin polymerization. It also impedes the proliferation of MDA-MB-231 breast cancer cells, exhibiting an IC50 value of 1.2 µM [1]. Target: Topoisomerase
Please request pricing for this article.
AuM1Gly
Item number: TGM-T82935-50mg
Description: AuM1Gly, a topoisomerase I inhibitor, demonstrates efficacy in inhibiting the proliferation of MDA-MB-231 breast cancer cells, exhibiting IC50 values in the low nanomolar range [1]. Target: Topoisomerase
Please request pricing for this article.
ATX-II TFA
Item number: TGM-T82936-5mg
Description: ATX-II TFA, a specific Na+ channel modulator toxin, is derived from the venom of the sea anemone (Anemonia sulcata). This compound impedes the inactivation of Na+ channels and has been associated with arrhythmogenesis in the pulmonary vein and atrial fibrillation [1] [2]. It interacts with halothane,...
2,399.00€
*
ATP Synthesis-IN-2
Item number: TGM-T82944-50mg
Description: ATP Synthesis-IN-2 (Compound 5) is a potent inhibitor of ATP synthesis activity, exhibiting significant antibacterial properties with an IC50 value of 0.7 µg/mL against Pseudomonas aeruginosa (PA) [1]. Target: Others
Please request pricing for this article.
ATP Synthesis-IN-1
Item number: TGM-T82945-50mg
Description: ATP Synthesis-IN-1 (Compound 4), a quinoline derivative, potently inhibits PA ATP synthesis with an IC50 of 11.1µg/mL and exhibits antibacterial properties. This compound is utilized in studying drug-resistant PA infections [1]. Target: Others
Please request pricing for this article.
Atisnolerbart
Item number: TGM-T82946-1mg
Description: Atisnolerbart, a human IgG4 antibody, specifically targets BETVIA, which is identified as the major birch pollen allergen, Bet v 1-A.
| CAS | 2456308-79-3 |
Please request pricing for this article.
Atinumab
Item number: TGM-T82947-10mg
Description: Atinumab (6A3-IgG4) is a monoclonal antibody inhibitor targeting reticulon-4 (Nogo) that stimulates the growth of neural protrusions and has immunomodulatory activity. Target: Others. References: Kucher K, Johns D, Maier D, Abel R, Badke A, Baron H, Thietje R, Casha S, Meindl R, Gomez-Mancilla B,...
| Keywords: | ATI355 , ATI 355 , 6A3-IgG4 |
From 183.00€
*
Atidortoxumab
Item number: TGM-T82949-1mg
Description: Atidortoxumab is a human monoclonal antibody (IgG1kappa) targeting Staphylococcus aureus alpha toxin [1].
| CAS | 1939108-95-8 |
Please request pricing for this article.